Aarti Drugs Ltd Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …
Aarti Drugs Ltd Company Profile :
Aarti Drugs Ltd is one of the leading pharmaceutical manufacturers in India. It is part of the USD 500 million Aarti Group of Industries.
Aarti Drugs is engaged in the business of manufacturing of pharmaceuticals. The company operates in the anti-diarrhea, anti-inflammatory and anti-biotic therapeutic segments. With its manufacturing facilities at Tarapur and Sarigam, the Company manufactures Vitamins, Anti-arthritis, Anti-fungal, Antibiotics, ACE inhibitors, besides its range in , anti-diabetic, anti-cholinergic, sedatives and anti-depressant drugs.
BSE Code : 524348
NSE Symbol : AARTIDRUGS
ISIN No. : INE767A01016
Industry : Pharmaceuticals
Face Value : Rs. 10.00
If you are an investor who has shares of Aarti Drugs or you are an stock market analyst then i am sure you might for Quarterly Results of Aarti Drugs.
In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Aarti Drugs. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Aarti Drugs.
Aarti Drugs Q1 Results 2016-17 :
Aarti Drugs will announce its Q1 FY 2016-17 Results in the month of July or early August 2016. We will update the table below once the results are out.
|(Values in Cr.)||01/03/2016 Standalone||01/03/2016 Consolidated|
Aarti Drugs will announce its Q2 FY 2016-17 Results in the month of October 2016.
Aarti Drugs will announce its Q3 FY 2016-17 Results in the month of January 2017.
Aarti Drugs will announce its Q4 FY 2016-17 Results in the month of April 2017.
Aarti Drugs will announce its FY 2016-17 Results in the month of April 2017.
Note : We will update the results table above as and when results are announced. Visit again.
Aarti Drugs Previous Year’s Results (FY 2015-16) :
|(Values in Cr.)||Standalone||Consolidated|
Note : If you like this information about Aarti Drugs Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.